The Metformin-FMD Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Ischemia Reperfusion InjuryEndothelial Function
Interventions
DRUG

Metformin

metformin 500 mg three times a day, for 3 days

DRUG

Pretreatment with metformin in combination of infusion of caffeine.

Pretreatment with metformin 500 mg three times a day for 3 days, in combination with pretreatment with caffeine (4 mg/kg intravenously over 10 minutes) prior to FMD measurement

DRUG

No pretreatment with metformin in combination with infusion of caffeine

No pretreatment with metformin in combination with pretreatment with caffeine (4 mg/kg intravenously over 10 minutes).

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01610401 - The Metformin-FMD Trial | Biotech Hunter | Biotech Hunter